Infinity Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Infinity Pharmaceuticals

14/05/2021 01:12

* Infinity Pharmaceuticals Inc  INFI.OQ  reported a quarterly
adjusted loss of 15 cents​​ per share for the quarter ended
in March. The mean expectation of six analysts for the quarter
was for a loss of 12 cents per share.
* Revenue rose 9.1% to $467.00 thousand from a year ago; 
analysts expected $1.15 million. 
* Infinity Pharmaceuticals Inc's reported EPS for the quarter
was a loss of 15 cents​.
* The mean earnings estimate of analysts had risen by about 4%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Infinity Pharmaceuticals Inc shares had fallen by 12.7% this
quarter and gained 33.0% so far this year.
* The company reported a quarterly loss of $11.63 million.
* Wall Street's median 12-month price target for Infinity
Pharmaceuticals Inc is $8.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 14 at 12:12 a.m. GMT.
​All figures in US dollars